PUBLISHER: QYResearch | PRODUCT CODE: 1862187
PUBLISHER: QYResearch | PRODUCT CODE: 1862187
The global market for Aspiration & Biopsy Needle was estimated to be worth US$ 1154 million in 2024 and is forecast to a readjusted size of US$ 1966 million by 2031 with a CAGR of 7.9% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Aspiration & Biopsy Needle cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Aspiration & Biopsy Needles are high-precision interventional medical devices widely used in clinical diagnostics and treatment to obtain tissue, cellular, or fluid samples from within the body, supporting oncology, image-guided interventions, pathology, and other fields of precision diagnosis and therapy planning. This product category includes fine-needle aspiration (FNA) and core biopsy needles, often used in conjunction with ultrasound, CT, and MRI imaging to ensure minimally invasive sampling, accurate localization, and safe operation. With advances in medical imaging and the growing adoption of personalized medicine, aspiration and biopsy needles are evolving from conventional diagnostic tools into critical components of precision healthcare, featuring innovations in high-performance materials, intelligent guidance systems, and single-use safety designs to meet higher clinical demands for convenience, patient comfort, and diagnostic accuracy.In 2024, global Aspiration & Biopsy Needles production reached approximately 54.36 million units, with an average global market price of around US$ 21.2 perunit.
The aspiration and biopsy needle sector is benefiting from global demographic aging, rising chronic disease prevalence, and increasing demand for early cancer screening. Annual reports from leading medtech companies highlight the growing clinical demand for high-precision, image-guided interventional devices, which is driving continuous investment. Government support for medical innovation and infrastructure upgrades across healthcare systems worldwide provide a strong foundation for long-term growth. Integration of AI-driven imaging analysis and robotic-assisted interventions is accelerating product innovation cycles and expanding market potential.The industry faces high technological barriers, stringent regulatory approval requirements, and intense international competition. As these devices are used for direct tissue sampling, manufacturers must comply with rigorous quality and safety standards, resulting in high R&D costs and long development timelines. Raw material price volatility, trade policy shifts, and regional market access restrictions also present operational risks. With market concentration increasing, sustained innovation and differentiation are crucial for maintaining competitive positioning.
With the rise of precision medicine, clinical needs are shifting from standalone puncture tools to integrated interventional solutions. Large hospitals and specialized oncology centers are increasingly demanding premium image-guided biopsy needles, while primary healthcare facilities prioritize cost-effective, user-friendly single-use products. The market is simultaneously moving toward both premiumization and mass adoption, with rapid demand growth in emerging regions such as Asia-Pacific, the Middle East, and Latin America, making them key targets for global players.
Core raw materials for aspiration and biopsy needles include medical-grade stainless steel, polymer coatings, and biocompatible plastics. Globalized supplier networks and long-term procurement agreements ensure consistent quality and supply stability. Premium products demand enhanced material hardness, surface finish, and biocompatibility, pushing the supply chain toward higher value-added solutions. With environmental regulations and sustainable manufacturing initiatives in focus, materials R&D is advancing toward biodegradable, high-strength alternatives, supporting the industry's long-term sustainable development.
This report aims to provide a comprehensive presentation of the global market for Aspiration & Biopsy Needle, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Aspiration & Biopsy Needle by region & country, by Type, and by Application.
The Aspiration & Biopsy Needle market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aspiration & Biopsy Needle.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Aspiration & Biopsy Needle manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Aspiration & Biopsy Needle in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Aspiration & Biopsy Needle in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.